- Home
- SRZN vs ACRE Comparison
SRZN vs ACRE Comparison
Compare SRZN & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRZN | ACRE |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 252.4M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | SRZN | ACRE |
|---|---|---|
| Price | $25.26 | $4.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $38.00 | $5.38 |
| AVG Volume (30 Days) | 249.8K | ★ 493.0K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | N/A | ★ 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $54,833,000.00 |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | $16.28 |
| P/E Ratio | ★ N/A | $3.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.55 | $4.11 |
| 52 Week High | $35.00 | $5.89 |
Technical Indicators
Market Signals| Indicator | SRZN | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 57.12 |
| Support Level | $20.26 | $4.67 |
| Resistance Level | $24.13 | $5.06 |
| Average True Range (ATR) | 1.89 | 0.14 |
| MACD | 0.25 | 0.03 |
| Stochastic Oscillator | 66.67 | 81.43 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.